| Detected | Trial | Change |
|---|---|---|
| 2026-08-05 | NCT07602868 A Comparative Study of Delayed Endoscopic DTI and Autologous Flap Reconstruction… |
Enrollment reduced: 588 -> 263 participants |
| 2026-08-04 | NCT07490990 Disitamab Vedotin Combined With Sintilimab and Multimodal Radiotherapy for HER2-Positive… |
Phase changed: not specified -> Phase 2 |
| 2026-08-04 | NCT07490990 Disitamab Vedotin Combined With Sintilimab and Multimodal Radiotherapy for HER2-Positive… |
Primary endpoint(s) modified |
| 2026-08-04 | NCT07490990 Disitamab Vedotin Combined With Sintilimab and Multimodal Radiotherapy for HER2-Positive… |
Trial arms changed: 0 -> 1 |
| 2026-08-02 | NCT06545630 Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06534840 Evaluation of Pulmonary Complications in Liver Transplantation Patients Based on Machine… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06266871 SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced… |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT06109207 Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT04318730 Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment… |
overall status: Recruiting → Unknown |
| 2026-07-31 | NCT07040943 Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory… |
Trial completed |
| 2026-07-31 | NCT07040943 Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory… |
date change Primary completion moved earlier: 2026-07-01 -> 2026-01-20 |
| 2026-07-30 | NCT07409805 YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After… |
Recruitment opened |
| 2026-07-30 | NCT07409805 YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After… |
date change Primary completion pushed: 2028-02-01 -> 2028-06-01 |
| 2026-07-30 | NCT07409805 YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After… |
date change Completion pushed: 2028-03-01 -> 2029-06-01 |
| 2026-07-22 | NCT07715279 Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression |
Primary endpoint(s) modified |
| 2026-07-22 | NCT06798363 Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of… |
Enrollment reduced: 40 -> 24 participants |
| 2026-07-19 | NCT07398664 H101 Plus TACE for r/m HNSCC |
Recruitment opened |
| 2026-07-19 | NCT07398664 H101 Plus TACE for r/m HNSCC |
date change Primary completion pushed: 2027-02-15 -> 2028-06-15 |
| 2026-07-19 | NCT07398664 H101 Plus TACE for r/m HNSCC |
date change Completion pushed: 2028-02-15 -> 2028-12-15 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07766226 Online Sharing for Head & Neck Cancer Support | Not Yet Recruiting | |
| 2026-08-13 | NCT07763301 YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies | Phase 1 | Recruiting |
| 2026-08-10 | NCT07755124 Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of… | Phase 1/2 | Not Yet Recruiting |
| 2026-08-03 | NCT07740993 A Single-Arm Study of Sintilimab and Disitamab Vedotin for Locally Advanced Eyelid… | Phase 2 | Not Yet Recruiting |
| 2026-07-31 | NCT07738159 Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary… | Phase 2 | Not Yet Recruiting |
| 2026-07-29 | NCT07733492 Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery | Not Yet Recruiting | |
| 2026-07-23 | NCT07724106 A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and… | Phase 1 | Not Yet Recruiting |
| 2026-07-21 | NCT07716423 Remote Versus On-Site Robotic Surgery for Hepatobiliary and Pancreatic Procedures | Not Yet Recruiting | |
| 2026-07-21 | NCT07718126 Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With… | Phase 2/3 | Not Yet Recruiting |
| 2026-07-20 | NCT07715279 Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07612774 | CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS | Coronary | Recruiting |
| NCT05624229 | Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding | Upper Gastrointestinal Hemorrhage | Not Yet Recruiting |
| NCT03685188 | Oxycodone and Sufentanil for Analgesia in Hip Surgery | Analgesia, Patient-Controlled | Enrolling by Invitation |
| NCT07665177 | Abrupt Discontinuation Versus Gradual Tapering of Propranolol in Infantile Hemangioma | Infantile Hemangioma (IH) | Not Yet Recruiting |
| NCT07689149 | Safety and Efficacy of BiTE in Desensitization Therapy for Highly Sensitized Kidney… | Kidney Transplantation Recipients | Not Yet Recruiting |
| Phase 3 | |||
| NCT07020247 | Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for… | Locally Advanced Rectal Cancer (LARC) | Recruiting |
| NCT07070622 | Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR) | Rectal Cancer | Recruiting |
| NCT06627712 | SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC | TNBC - Triple-Negative Breast Cancer | Recruiting |
| NCT07467083 | Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for… | Head and Neck Cancer | Recruiting |
| NCT06663956 | A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management | Cancer Pain | Recruiting |
| NCT04922853 | Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for… | Rectal Cancer | Active, Not Recruiting |
| NCT07239674 | Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC | Intermediate-to-High Risk Differentiated Thyroid Cancer | Not Yet Recruiting |
| NCT07274696 | Mecobalamin in Promoting Recurrent Laryngeal Nerve Function Recovery After Thyroid Surgery | Patients Undergoing Open Thyroid Surgery | Not Yet Recruiting |
| NCT07336953 | A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus… | PDAC - Pancreatic Ductal Adenocarcinoma | Not Yet Recruiting |
| NCT07593846 | The Comparison Between DEDTI BR and T/E BR | Breast Cancer | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT04316039 | Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade… | Low-grade Glioma | Recruiting |
| NCT06673290 | Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations | Lymphatic Malformation | Recruiting |
| NCT07353671 | Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis | Radiation-induced Dermatitis | Recruiting |
| NCT06798363 | Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of… | Infantile Hemangioma | Recruiting |
| NCT07608224 | HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable… | Urinary Bladder Neoplasms | Not Yet Recruiting |
| NCT07718126 | Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With… | Metabolic Dysfunction-Associated Steatohepatitis | Not Yet Recruiting |
| Phase 2 | |||
| NCT05447702 | Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in… | Triple Negative Breast Cancer | Recruiting |
| NCT06437158 | Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients | Lymphatic Malformation | Recruiting |
| NCT06341296 | Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal… | Metastatic Colorectal Cancer | Recruiting |
| NCT06664996 | Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT | Hepatocellular Carcinoma (HCC) | Recruiting |